Paul L. Foster School of Medicine, Texas Tech Health Sciences Center El Paso, El Paso, TX, US.
Department of Internal Medicine, University of Texas Health Science Center At Houston, Houston, TX, US.
Arch Dermatol Res. 2022 May;314(4):329-340. doi: 10.1007/s00403-021-02224-z. Epub 2021 Apr 28.
Melanoma-screening examinations support early diagnosis, yet there is a national shortage of dermatologists and most at-risk patients lack access to dermatologic care. Primary care physicians (PCPs) in the United States often bridge these access gaps, and thus, play a critical role in the early detection of melanoma. However, most PCPs do not offer skin examinations. We conducted a systematic review and searched Ovid MEDLINE, EMBASE, and the Cochrane Library from 1946 to July 2019 to identify barriers for skin screening by providers, patients, and health systems following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Of 650 abstracts initially identified, 111 publications were included for full-text review and 48 studies met the inclusion criteria. Lack of dermatologic training (89.4%), time constraints (70%), and competing comorbidities (51%) are the most common barriers reported by PCPs. Low perceived risk (69%), long delays in appointment (46%), and lack of knowledge about melanoma (34.8%) are most frequently reported patient barriers. Qualitative reported barriers for health system are lack of public awareness, social prejudice leading to tanning booth usage, public surveillance programs requiring intensive resources, and widespread ABCD evaluation causing delays in seeking medical attention for melanomas. Numerous barriers remain that prevent the implementation of skin screening practices in clinical practice. A multi-faceted combination of efforts is essential for the execution of acceptable and effective skin cancer-screening practices, thus, increasing early diagnosis and lowering mortality rates and burden of disease for melanoma.
黑色素瘤筛查检查有助于早期诊断,但美国皮肤科医生短缺,大多数高危患者无法获得皮肤科护理。美国的初级保健医生(PCP)经常填补这些服务差距,因此在黑色素瘤的早期检测中发挥着关键作用。然而,大多数 PCP 并不提供皮肤检查。我们按照系统评价和荟萃分析的首选报告项目(PRISMA)报告准则,进行了系统评价并检索了 1946 年至 2019 年 7 月期间的 Ovid MEDLINE、EMBASE 和 Cochrane 图书馆,以确定提供者、患者和卫生系统进行皮肤筛查的障碍。在最初确定的 650 篇摘要中,有 111 篇进行了全文审查,有 48 项研究符合纳入标准。PCP 报告的最常见障碍包括缺乏皮肤科培训(89.4%)、时间限制(70%)和并存疾病(51%)。低风险感知(69%)、预约时间长(46%)和缺乏对黑色素瘤的了解(34.8%)是患者报告的最常见障碍。卫生系统报告的定性障碍包括公众意识缺乏、导致使用日光浴床的社会偏见、需要密集资源的公共监督计划以及广泛的 ABCD 评估导致黑色素瘤寻求医疗关注的延迟。仍然存在许多障碍,这些障碍阻止了皮肤筛查实践在临床实践中的实施。必须采取多方面的综合努力,才能实施可接受和有效的皮肤癌筛查实践,从而提高早期诊断水平,降低黑色素瘤的死亡率和疾病负担。